[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS5763A - Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf - Google Patents

Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf

Info

Publication number
IS5763A
IS5763A IS5763A IS5763A IS5763A IS 5763 A IS5763 A IS 5763A IS 5763 A IS5763 A IS 5763A IS 5763 A IS5763 A IS 5763A IS 5763 A IS5763 A IS 5763A
Authority
IS
Iceland
Prior art keywords
drug
composition containing
nutritional supplement
inositol phosphate
containing carnitine
Prior art date
Application number
IS5763A
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of IS5763A publication Critical patent/IS5763A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IS5763A 1999-04-22 2000-12-08 Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf IS5763A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en) 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (1)

Publication Number Publication Date
IS5763A true IS5763A (is) 2000-12-08

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5763A IS5763A (is) 1999-04-22 2000-12-08 Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf

Country Status (26)

Country Link
US (1) US6565876B1 (is)
EP (1) EP1119363B1 (is)
JP (1) JP2002542282A (is)
KR (1) KR20010053023A (is)
CN (1) CN1359295A (is)
AR (1) AR023391A1 (is)
AT (1) ATE299370T1 (is)
AU (1) AU776591B2 (is)
BR (1) BR0006076A (is)
CA (1) CA2335015C (is)
DE (1) DE60021247T2 (is)
DK (1) DK1119363T3 (is)
EE (1) EE200000742A (is)
ES (1) ES2243254T3 (is)
HU (1) HU227357B1 (is)
IL (1) IL140164A0 (is)
IS (1) IS5763A (is)
IT (1) IT1306133B1 (is)
NO (1) NO20006429L (is)
PL (1) PL197885B1 (is)
PT (1) PT1119363E (is)
SI (1) SI1119363T1 (is)
SK (1) SK19322000A3 (is)
TN (1) TNSN00083A1 (is)
TR (1) TR200003737T1 (is)
WO (1) WO2000064426A2 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
PL1863495T3 (pl) * 2005-03-18 2015-06-30 Normoxys Inc Sól wapniowa 1,6:2,3:4,5-tripirofosforanu mioinozytolu jako efektor allosteryczny hemoglobiny w leczeniu raka
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
US20110217252A1 (en) * 2008-11-11 2011-09-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
SG10201503032UA (en) * 2010-06-16 2015-06-29 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
KR20220012903A (ko) * 2019-05-23 2022-02-04 이케이와이제이 컨설팅 투 엘엘씨 알코올-유발성 피부 안면홍조의 치료 및 완화를 위한 조성물 및 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
WO2000064426A3 (en) 2001-05-25
WO2000064426A2 (en) 2000-11-02
ES2243254T3 (es) 2005-12-01
ITRM990248A1 (it) 2000-10-22
CA2335015A1 (en) 2000-11-02
SI1119363T1 (en) 2005-10-31
TR200003737T1 (tr) 2001-07-23
CA2335015C (en) 2008-03-18
EP1119363A2 (en) 2001-08-01
HUP0102926A3 (en) 2002-12-28
DE60021247T2 (de) 2006-04-27
IT1306133B1 (it) 2001-05-30
SK19322000A3 (sk) 2001-06-11
HUP0102926A2 (hu) 2002-03-28
AU776591B2 (en) 2004-09-16
DE60021247D1 (de) 2005-08-18
KR20010053023A (ko) 2001-06-25
TNSN00083A1 (fr) 2005-11-10
CN1359295A (zh) 2002-07-17
NO20006429L (no) 2001-02-20
EE200000742A (et) 2002-04-15
PL197885B1 (pl) 2008-05-30
BR0006076A (pt) 2001-03-20
US6565876B1 (en) 2003-05-20
DK1119363T3 (da) 2005-10-17
JP2002542282A (ja) 2002-12-10
IL140164A0 (en) 2002-02-10
EP1119363B1 (en) 2005-07-13
PL346160A1 (en) 2002-01-28
ATE299370T1 (de) 2005-07-15
HU227357B1 (en) 2011-04-28
AU4313500A (en) 2000-11-10
AR023391A1 (es) 2002-09-04
PT1119363E (pt) 2005-09-30
NO20006429D0 (no) 2000-12-15

Similar Documents

Publication Publication Date Title
GB9916536D0 (en) Nutritional or pharmaceutical compositions
HUP0204372A3 (en) Pharmaceutical compositions providing enhanced drug concentrations
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
IS5763A (is) Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf
PT1052974E (pt) Formulação farmacêutica contendo epotilona
IL147970A0 (en) Pharmaceutical compositions containing tripeptides
IS7304A (is) Tvívetnissetin pýrasólýlbensýlsúlfónamíð og lyf sem innihalda téð efnasambönd
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
HUP0201826A3 (en) Use of creatine as a nutritional supplement
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL136612A (en) Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
GB0101051D0 (en) Dietary supplement
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
GB9820815D0 (en) Improvementsin or relating to nutritional and pharmaceutical compositions
GB9818927D0 (en) Pharmaceutical formulation
PL337807A1 (en) Sertralin dosage formulation in the form of a gelatine-encapsulated solution
IL138994A0 (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
GB9817470D0 (en) Pharmaceutical formulation
AP2002002402A0 (en) Streptogramin derivatives production thereof and compositions containing the same
HUP0500956A3 (en) Oxapenem-3-carboxylic acids and pharmaceutical compositions containing them
GB9802617D0 (en) Pharmaceutical formulation
HUP0103302A3 (en) Polyhydroalkylpyrazine derivatives their preparation and medicines containing them